C26H26B10Zn4S2, monoclinic, P21/n, a = 14.3766(13) Å, b = 11.6360(11) Å, c = 18.9460(15) Å, β = 104.9630(10)°, V = 3061.9(5) Å3, Z = 4, Rgt(F) = 0.0451, wRref(F2) = 0.0999, T = 298(2) K [1–3]
C34H34N10O9Zn, monoclinic, P1̄ (no. 2), a = 10.1188(13) Å, b = 12.9297(16) Å, c = 15.0668(19) Å, α =...
C25H22Cl2N4O5Zn, monoclinic, P21/c (no. 14), a = 16.302(3) Å, b = 11.324(2) Å, c = 14.636(3) Å, β = ...
C41H45Br8N7O7Zn2, triclinic, P1̄ (no. 2), a = 13.7022(5) Å, b = 13.8771(7) Å, c = 14.0928(5) Å, α = ...
C40H28Cl4N4O4Zn, monoclinic, C2/c (no. 19), a = 26.573(4) Å, b = 12.898(2) Å, c = 11.4503(17) Å, β =...
C26H18N6ZnS4, triclinic, P1‾$P‾{1}$ (no. 2), a = 9.4677(13) Å, b = 12.0147(17) Å, c = 13.571(...
C28H22N2O4Zn, tetragonal, P41212 (no. 92), a = 10.986(5) Å, b = 10.986(5) Å, c = 18.187(8) Å, V = 21...
C20H30N4O4P2S4Zn, triclinic, P1̄ (no. 2), a = 8.01840(1) Å, b = 8.4326(1) Å, c = 23.5086(2) Å, α = 8...
C20H12Br2N4O7Zn, orthorhombic, Pbca (no. 61), a = 22.593(7) Å, b = 7.220(2) Å, c = 26.225(8) Å, V = ...
C30H28N6O4Zn, orthorhombic, Aba2 (no. 41), a = 12.040(9) Å, b = 22.596(18) Å, c = 10.344(10) Å, V = ...
C25H28N6O7Zn, triclinic, P1̄ (no. 2), a = 7.8073(19) Å, b = 11.350(3) Å, c = 15.515(4) Å, α = 95.006...
C32H30N4O4Zn, triclinic, P1̅ (no. 2), a = 8.6632(8) Å, b = 12.7133(10) Å, c = 14.2719(12) Å, α = 98....
The asymmetric unit in the crystal structure of the title compound, [Zn2(C16H14N2S2) 2]2·0.18C2H6OS·...
C10H18O6Zn, monoclinic, P2/c (no. 13), a = 11.0730(2) Å, b = 5.52600(10) Å, c = 10.8410(2) Å, β = 10...
C32H34N10O6S2Zn, monoclinic, C2/c (no. 15), a = 24.243(4) Å, b = 11.2766(17) Å, c = 15.799(5) Å, β =...
The common feature of the title compounds, [Zn(C5H10NO2S2)2(C10H8N2)]·2H2O, (I), and [Zn(C6H12NOS2)2...
C34H34N10O9Zn, monoclinic, P1̄ (no. 2), a = 10.1188(13) Å, b = 12.9297(16) Å, c = 15.0668(19) Å, α =...
C25H22Cl2N4O5Zn, monoclinic, P21/c (no. 14), a = 16.302(3) Å, b = 11.324(2) Å, c = 14.636(3) Å, β = ...
C41H45Br8N7O7Zn2, triclinic, P1̄ (no. 2), a = 13.7022(5) Å, b = 13.8771(7) Å, c = 14.0928(5) Å, α = ...
C40H28Cl4N4O4Zn, monoclinic, C2/c (no. 19), a = 26.573(4) Å, b = 12.898(2) Å, c = 11.4503(17) Å, β =...
C26H18N6ZnS4, triclinic, P1‾$P‾{1}$ (no. 2), a = 9.4677(13) Å, b = 12.0147(17) Å, c = 13.571(...
C28H22N2O4Zn, tetragonal, P41212 (no. 92), a = 10.986(5) Å, b = 10.986(5) Å, c = 18.187(8) Å, V = 21...
C20H30N4O4P2S4Zn, triclinic, P1̄ (no. 2), a = 8.01840(1) Å, b = 8.4326(1) Å, c = 23.5086(2) Å, α = 8...
C20H12Br2N4O7Zn, orthorhombic, Pbca (no. 61), a = 22.593(7) Å, b = 7.220(2) Å, c = 26.225(8) Å, V = ...
C30H28N6O4Zn, orthorhombic, Aba2 (no. 41), a = 12.040(9) Å, b = 22.596(18) Å, c = 10.344(10) Å, V = ...
C25H28N6O7Zn, triclinic, P1̄ (no. 2), a = 7.8073(19) Å, b = 11.350(3) Å, c = 15.515(4) Å, α = 95.006...
C32H30N4O4Zn, triclinic, P1̅ (no. 2), a = 8.6632(8) Å, b = 12.7133(10) Å, c = 14.2719(12) Å, α = 98....
The asymmetric unit in the crystal structure of the title compound, [Zn2(C16H14N2S2) 2]2·0.18C2H6OS·...
C10H18O6Zn, monoclinic, P2/c (no. 13), a = 11.0730(2) Å, b = 5.52600(10) Å, c = 10.8410(2) Å, β = 10...
C32H34N10O6S2Zn, monoclinic, C2/c (no. 15), a = 24.243(4) Å, b = 11.2766(17) Å, c = 15.799(5) Å, β =...
The common feature of the title compounds, [Zn(C5H10NO2S2)2(C10H8N2)]·2H2O, (I), and [Zn(C6H12NOS2)2...
C34H34N10O9Zn, monoclinic, P1̄ (no. 2), a = 10.1188(13) Å, b = 12.9297(16) Å, c = 15.0668(19) Å, α =...
C25H22Cl2N4O5Zn, monoclinic, P21/c (no. 14), a = 16.302(3) Å, b = 11.324(2) Å, c = 14.636(3) Å, β = ...
C41H45Br8N7O7Zn2, triclinic, P1̄ (no. 2), a = 13.7022(5) Å, b = 13.8771(7) Å, c = 14.0928(5) Å, α = ...